XMAX XMAX
Company Profile ↓Company Overview
XMAX (XMAX) is a publicly traded company listed on with a market capitalization of $361.05M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 26.7% per year over the last five years.
Carries low leverage with a debt-to-equity ratio of 0.22.
Recent Developments
- Dec 2025 Revenue of $16.72M (+72.6% YoY); net profit $-3.42M.
- Trailing 12 Months Year-on-year growth — revenue +72.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 9.5%, profit CAGR 26.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 9.48% |
| 1 Year: | 72.63% |
Compounded Profit Growth
| 5 Years: | 26.67% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +266.81% |
| 6 Months: | +49.13% |
| 3 Months: | +6.82% |
| 1 Month: | -5.79% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)52.07 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 26.7% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 2.64M | 2.56M | 9.76M | 1.77M | 1.78M |
| Cost of Revenue | 1.43M | 1.27M | 8.78M | 1.06M | 899.25K |
| Gross Profit | 1.20M | 1.28M | 983.80K | 712.41K | 882.47K |
| Operating Expenses | 1.40M | 1.48M | 1.47M | 1.76M | 1.42M |
| Operating Income | -193.36K | -196.49K | -490.02K | -1.05M | -534.85K |
| EBITDA | 4.72K | 3.83K | -306.49K | -2.74M | -372.35K |
| Interest Expense | - | - | - | - | - |
| Pretax Income | -401.13K | -290.90K | -1.13M | -2.18M | 191.51K |
| Tax Provision | -62.26K | -997 | -757 | -516.97K | 0 |
| Net Income | -338.87K | -289.91K | -1.13M | -1.66M | 191.51K |
| Diluted EPS | -0.03 | -0.02 | -0.06 | - | 0.00 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 12.74M | 11.09M | 9.69M | 16.72M |
| Cost of Revenue | - | 20.53M | 6.91M | 5.44M | 12.54M |
| Gross Profit | - | -7.78M | 4.17M | 4.25M | 4.18M |
| Operating Expenses | - | 8.44M | 10.59M | 9.61M | 6.11M |
| Operating Income | - | -16.22M | -6.42M | -5.36M | -1.93M |
| EBITDA | - | -15.65M | -6.18M | -5.02M | -3.04M |
| Interest Expense | - | - | 9.49K | 31.24K | 77.14K |
| Pretax Income | - | -17.07M | -6.99M | -5.56M | -4.00M |
| Tax Provision | - | 2.40K | 731.09K | 2.61K | -580.99K |
| Net Income | - | -17.10M | -7.72M | -5.56M | -3.42M |
| Diluted EPS | - | -12.34 | -4.96 | -1.48 | -0.17 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 11.53M | 6.24M | 9.92M | 35.55M |
| Current Assets | - | 8.20M | 3.75M | 7.93M | 11.78M |
| Cash & Equivalents | - | 1.37M | 369.14K | 161.90K | 6.71M |
| Inventory | - | 4.93M | 2.21M | 2.82M | 2.16M |
| Receivables | - | 288.48K | 47.00K | 36.37K | 2.45M |
| Total Liabilities | - | 4.92M | 5.74M | 6.79M | 7.59M |
| Current Liabilities | - | 1.64M | 3.69M | 5.83M | 2.39M |
| Long Term Debt | - | 150.00K | 147.43K | 197.83K | 5.18M |
| Total Debt | - | 2.86M | 2.11M | 2.12M | 6.21M |
| Total Equity | - | 6.61M | 496.35K | 3.12M | 27.96M |
| Shares Outstanding | - | 1.42M | 1.92M | 7.30M | 41.89M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -5.37M | -1.58M | -1.39M | -445.84K |
| Investing Cash Flow | - | -8.77K | 18.64K | -14.12K | -22.81M |
| Financing Cash Flow | - | 0 | 0 | 1.18M | 29.75M |
| Capital Expenditure | -110.52K | -8.77K | - | -14.12K | - |
| Free Cash Flow | - | -5.38M | -1.58M | -1.41M | -445.84K |
| Net Change in Cash | - | -5.38M | -1.56M | -230.32K | 6.50M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | -61.1% | 37.6% | 43.9% | 25.0% |
| Operating Margin % | - | -127.3% | -57.9% | -55.4% | -11.5% |
| Net Margin % | - | -134.2% | -69.7% | -57.4% | -20.4% |
| ROE % | - | -258.7% | -1,556.0% | -178.1% | -12.2% |
| ROCE % | - | -164.0% | -251.8% | -131.1% | -5.8% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for XMAX
XMAX — Frequently Asked Questions
What is the current share price of XMAX?
As of 2026-08-02 19:16 PDT, XMAX trades at $8.62 on NASDAQ/NYSE. Its 52-week range is $1.66 to $9.15.
What is the market capitalisation of XMAX?
XMAX has a market capitalisation of $361.05M on NASDAQ/NYSE.
What is the P/E ratio of XMAX?
XMAX trades at a trailing price-to-earnings (P/E) ratio of -50.71. Its price-to-book (P/B) ratio is 12.91.
What is the return on equity (ROE) of XMAX?
XMAX has a return on equity (ROE) of -12.23%. Its return on capital employed (ROCE) is -11.83%.
Is XMAX a good stock to buy?
This page provides a data-driven analysis of XMAX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.